Christopher R. Fenimore, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,896 shares at $856.71 ($4.2M) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Scheduled sale ($4.2M) by SVP Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $856.71 | 2,448 | $2.1M | 50.0% |
| 2 | $856.71 | 2,448 | $2.1M | 50.0% |
| Total | $856.71 avg | 4,896 | $4.2M | 100% |
| Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |
| REGN | SELL | 2022-10-07 | $1.4M | — | Filing → |